These findings may help to better understand how abnormalities in NKCC2 protein trafficking lead to Bartter’s syndrome which is essential for elucidating the pathophysiology of BS1 and for improving the available treatments. This evidence concerns the gene SLC12A1 and Bartter syndrome.